文献速递银屑病与炎症性皮肤病

银屑病患者心脏结构与功能:PSOCADIA研究横断面分析

Cardiac structure and function in psoriasis: A cross-sectional analysis of the PSOCADIA study.
PubMed 文献 · J Eur Acad Dermatol Venereol · 2026-07-17

PSOCADIA研究纳入1010例银屑病成人及1010例年龄性别匹配对照,进行临床评估和经胸超声心动图。银屑病患者异常GLS(<16%)定义的亚临床心肌功能障碍更常见(16.7% vs. 6.0%,p<0.001),且独立于心血管代谢危险因素和动脉粥样硬化性心血管疾病;心脏结构与功能在银屑病不同严重程度间基本相似。

要点

  • 银屑病患者异常GLS心肌功能障碍患病率高于对照(16.7% vs. 6.0%)。
  • 该关联独立于心血管代谢危险因素和动脉粥样硬化性心血管疾病。
  • 心肌功能障碍在银屑病不同严重程度间相似,所有患者均需心血管评估。

核心结论

  • 银屑病患者即使皮肤病变管理良好,仍存在较高的心肌功能障碍负担,且独立于心血管代谢共病。

研究设计与样本

  • 前瞻性PSOCADIA队列的横断面分析,纳入1010例银屑病成人及1010例年龄性别匹配无炎症性皮肤病对照,均接受临床评估和经胸超声心动图。

主要发现

  • 银屑病患者异常GLS(<16%)患病率为16.7%,对照为6.0%(p<0.001)。
  • 调整心血管代谢危险因素和动脉粥样硬化性心血管疾病后,关联持续存在。
  • 心脏结构与功能在银屑病不同严重程度间基本相似。
  • 较高体重指数和糖尿病与银屑病心肌功能障碍独立相关。

关键数值与推荐

  • 心肌功能障碍定义为整体纵向应变(GLS)<16%。

临床怎么用

  • 所有银屑病患者均应重视心血管评估,即使皮肤病变轻微或控制良好。
  • 对合并较高体重指数或糖尿病的银屑病患者,应关注心肌功能监测。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Psoriasis is linked to an increased risk of cardiovascular disease, but the impact of psoriasis on cardiac structure and function has been less clear. OBJECTIVES: To assess cardiac structure, function and cardiometabolic risk factors in individuals with psoriasis compared with matched controls and across psoriasis severity. METHODS: Cross-sectional analysis of 1010 adults with psoriasis from the prospective PSOCADIA cohort and 1010 age- and sex-matched controls without inflammatory skin disease. Participants underwent clinical assessment and transthoracic echocardiography. Cardiac abnormalities assessed included hypertrophy, valvular disease, systolic and diastolic dysfunction, and myocardial dysfunction defined by global longitudinal strain (GLS) <16%. RESULTS: Despite well-managed skin disease, individuals with psoriasis had more prevalent myocardial dysfunction by abnormal GLS (16.7% vs. 6.0%, p < 0.001) compared with controls. This association persisted after adjustment for cardiometabolic risk factors and atherosclerotic cardiovascular disease. Cardiac structure and function were largely similar across psoriasis severity. Higher body mass index and diabetes were independently associated with myocardial dysfunction in psoriasis. CONCLUSIONS: Individuals with psoriasis, even with well-managed skin disease, exhibit a higher burden of myocardial dysfunction compared with controls, independent of cardiometabolic comorbidity. The prevalence was similar across psoriasis severity, highlighting the importance of cardiovascular assessment in all patients with psoriasis. CLINICALTRIALS: GOV: NCT04950218 (Prevalence and risk factors asSOciated with CArdiac comorbiDIty in psoriAsis, registered on 6 July 2021). UNLABELLED: WHAT IS THE DISEASE?: Psoriasis is a common chronic inflammatory skin condition that affects about 2–3% of adults. It causes red, scaly patches on the skin and is linked to a higher risk of heart and blood vessel diseases due to ongoing inflammation and shared risk factors. LOCATION OF THE STUDY: The study was conducted in the greater Copenhagen area, Denmark. AIM OF THE STUDY: We investigated whether people with psoriasis have differences in heart structure and function compared with people without psoriasis, and whether these changes are related to psoriasis severity. METHODOLOGY: This study included 1010 adults with psoriasis and 1010 matched individuals without skin disease from the general population. Participants underwent detailed heart ultrasound examinations, including advanced imaging to detect subtle heart muscle changes. Clinical information on health, lifestyle and blood tests was also collected. KEY FINDINGS: People with psoriasis had more common risk factors such as higher body weight, high blood pressure and diabetes. Overall, heart‐pumping function was similar between groups. However, subtle signs of heart muscle dysfunction were more common in psoriasis, even when skin disease was well controlled. These changes were not related to psoriasis severity. Higher body weight and diabetes were linked to worse heart function in psoriasis. CONCLUSIONS AND PRACTICAL IMPLICATIONS: Psoriasis is associated with early, subtle changes in heart function that may not be detected by routine tests. This suggests that people with psoriasis may benefit from careful monitoring of cardiovascular risk factors, even when their skin disease is mild or well‐controlled.

来源:J Eur Acad Dermatol Venereol,查看原文。版权归原作者所有。

引用

  1. Dons M, Sengeløv M, Skaarup KG, et al. Cardiac structure and function in psoriasis: A cross-sectional analysis of the PSOCADIA study. J Eur Acad Dermatol Venereol. 2026. PMID: 42466607. doi:10.1111/jdv.70609

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。